Dr. Raam Sambandam, MD

Dr. Sambandam practices at Synapse Neurological Care P.a. in Clermont, Florida.

Dr. Sambandam's NPI, 1528226388, was assigned on May 29, 2008. Dr. Sambandam graduated from Royal College of Surgeons Ireland in 2004. Dr. Sambandam holds Florida license ME113968.

Dr. Sambandam's primary practice is Synapse Neurological Care P.a., at 2753 Citrus Tower Blvd, Clermont, FL 34711-6699. The practice phone is (352) 404-7570.

Dr. Sambandam's primary practice is Synapse Neurological Care P.a. in Clermont, Florida. Dr. Sambandam is also affiliated with Orlando Health South Lake Hospital. The medical group on file is Ability Rehabilitation. Dmand AI also links Dr. Sambandam to 4 more hospitals, 3 medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sambandam practices, 8 sites in all. Vendor and product names are available with a free account.

Clinical neurophysiology is Dr. Sambandam's primary specialty in the NPI Registry, under taxonomy code 2084N0600X. Dr. Sambandam is board certified in brain injury medicine by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Sambandam's licenses on file in 3 states: Florida, Virginia and Georgia.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, cerebrovascular disease, epilepsy, essential tremor, fibromyalgia and chronic pain and hereditary polyneuropathy among the conditions Dr. Sambandam treats.

CMS data shows 233,171 Medicare services from Dr. Sambandam across 26 procedure codes in 2024, for 897 Medicare patients. Medicare paid $1,726,871 for them.

CMS counts 897 Medicare patients who saw Dr. Sambandam in 2024. The largest group is 75 to 84, with 422 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sambandam's median patient age at 69, with 59% women.

In 2024, Dr. Sambandam wrote 3,883 Medicare Part D claims for 791 patients. 80% of them were for generic drugs. CMS names the drug for 3,430 of them, across 72 drugs with 11 or more claims each, at $3,542,475 in total drug cost. In 2023, CMS named 3,061 claims across 66 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Sambandam for performance year 2024, reported individually. Dr. Sambandam accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 14 procedures of skin biopsy by Dr. Sambandam, more than 61% of the clinicians it reports for that procedure.

Dmand AI links 2 papers to Dr. Sambandam in 2012. Dr. Sambandam's most frequent co-authors are Scott Lee Silliman, MD, Leslie Miller, MD and Andrew Rathnasamy Xavier, MD.

CMS Open Payments shows 1,920 general payments to Dr. Sambandam from 81 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 37% of the total. Eli Lilly and Company paid the most, $26,955.

Dr. Sambandam graduated from Royal College of Surgeons Ireland in 2004.

Dr. Sambandam is in network with 14 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.